4014: A Phase 4 Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment OutcomesIn Nonresponders With Moderately to Severely Active Ulcerative Colitis (ENTERPRET)

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry